COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,722 Articles (22,913 medRxiv, 8,809 bioRxiv)

Most recent first Previous |  Page 3037: Articles 30361-30370  | Next

Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus
Temmam, S., Barbarino, A., Maso, D., Behillil, S., Enouf, V., Huon, C., Jaraud, A., Chevallier, L., Backovic, M., Perot, P., Verwaerde, P., Tiret, L., van der Werf, S., Eloit, M.
10.1101/2020.04.07.029090 — Posted: 2020-04-09 Discussion: Onsite | Offsite
The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro.
Bukreyeva, N., Mantlo, E. K., Sattler, R. A., Huang, C., Paessler, S., Zeldis, J.
10.1101/2020.04.07.028589 — Posted: 2020-04-09
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Corti, D., Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., Peter, A., Guarino, B., Spreafico, R., Cameroni, E., Case, J. B., Chen, R. E., Havenar-Daughton, C., Snell, G., Telenti, A., Virgin, H. W., Lanzavecchia, A., Diamond, M. S., Fink, K., Veesler, D.
10.1101/2020.04.07.023903 — Posted: 2020-04-09 Discussion: Onsite
Targeting the catecholamine-cytokine axis to prevent SARS-CoV-2 cytokine storm syndrome
Konig, M. F., Powell, M., Staedtke, V., Bai, R.-Y., Thomas, D. L., Fischer, N., Huq, S., Khalafallah, A. M., Koenecke, A., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., Vogelstein, J. T., Athey, S., Zhou, S., Bettegowda, C.
10.1101/2020.04.02.20051565 — Posted: 2020-04-08
Data-Driven Study of the the COVID-19 Pandemic via Age-Structured Modelling and Prediction of the Health System Failure in Brazil amid Diverse Intervention Strategies
Canabarro, A., Tenorio, E., Martins, R., Martins, L., Brito, S., Chaves, R.
10.1101/2020.04.03.20052498 — Posted: 2020-04-08
Chloroquine and hydroxychloroquine for the treatment of COVID-19: A living systematic review protocol
Bravo Jeria, R., Rojas Reyes, M. X., Franco, J. V., Acuna, M. P., Torres Lopez, L. A., Rada, G. r., COVID-19 L-OVE Working Group
10.1101/2020.04.03.20052530 — Posted: 2020-04-08
Lack of Antiviral Activity of Darunavir against SARS-CoV-2
De Meyer, S., Bojkova, D., Cinati, J., Van Damme, E., Buyck, C., Van Loock, M., Woodfall, B., Ciesek, S.
10.1101/2020.04.03.20052548 — Posted: 2020-04-08
Interaction between malarial transmission and BCG vaccination with COVID-19 incidence in the world map: A changing landscape human immune system?
Goswami, R. P., Mittal, D. K., Goswami, R. P.
10.1101/2020.04.03.20052563 — Posted: 2020-04-08
Optimize Clinical Laboratory Diagnosis of COVID-19 from Suspect Cases by Likelihood Ratio of SARS-CoV-2 IgM and IgG antibody
Yangchun, F.
10.1101/2020.04.07.20053660 — Posted: 2020-04-08
Derivation of the effective reproduction number R for COVID-19 in relation to mobility restrictions and confinement
Arenas, A., Cota, W., Gomez-Gardenes, J., Gomez, S., Granell, C., Matamalas, J. T., Soriano-Panos, D., Steinegger, B.
10.1101/2020.04.06.20054320 — Posted: 2020-04-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).